NEW DELHI : Pfizer Inc has withdrawn its application for emergency licensure in India for now after a subject expert committee of the Indian regulator sought additional information from the company on Wednesday, a spokesperson for the company said on Friday.“Based on the deliberations at the meeting and our understanding of additional information that the regulator may need, the company has decided to withdraw its application at this time.
Pfizer will continue to engage with the authority and resubmit its approval request with additional information as it becomes available in the near future," the spokesperson said.Also Read | Vaccination drive picks up slowlyWhile the nature of the information sought by the SEC is not yet known, the.